Who we are

Ultimately, we're about the patient.

At Norstella, our mission is simple: to help patients gain access to life-saving therapies.

We turn that into a reality by helping our clients navigate the complexities at each step of the drug development life cycle, from pipeline to patient.

Stronger, together

As one of the largest global pharma intelligence solutions providers, Norstella unites market-leading companies that all have a shared goal of improving patient access.

Each organization (Citeline, Evaluate, MMIT, Panalgo, The Dedham Group) delivers must-have answers for critical strategic and commercial decision-making. Together, we help our clients:

  • Assess the market need and competitive landscape
  • Know precisely which drugs to prioritize in their portfolios
  • Connect the dots between patients and clinical trials
  • Reduce costs, mitigate risk and stay in compliance
  • Find out where the launch difficulties will be—before they’re difficulties

By combining the efforts of each organization under Norstella, we can offer an even wider breadth of expertise, cutting-edge data solutions and expert advisory services alongside advanced technologies such as real-world data, machine learning and predictive analytics.

At Norstella, we don’t just deliver information and insights. We deliver answers you can act on.


Accelerate the drug development cycle

Bring the right
drugs to market

Identify barriers
to patient access

Turn data into
insights faster

Think strategically for
specialty therapeutics



Values-driven leadership

We have the data, technology and information you need to make the right decisions—and the right people who can guide you along the way.

Work with us

Join our mission

We're looking for agile, growth-oriented team players who are passionate about client success and helping patients get access to the therapies they need.

Work with us

Get in Touch

Let's connect

Have questions about Norstella or its brands? Or do you want to know more about how to solve your market access challenges?

We want to hear from you